Compound Detail
CHEMBL1908394
GSK-461364 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F
Basic Information
| ChEMBL ID | CHEMBL1908394 |
| Name | GSK-461364 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | ZHJGWYRLJUCMRT-QGZVFWFLSA-N |
68
Targets
89
Activities
3
Assay Types
0
PK Parameters
20
Publications
4
Known Names
1
Indications
1
Mechanisms
Molecular Properties
543.6
MW (Da)
5.09
ALogP
7
HBA
1
HBD
76.6
PSA (Ų)
0.35
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase PLK1 inhibitor | INHIBITOR | Serine/threonine-protein kinase PLK1 | ✓ | ✓ |
Indications
Lymphoma, Non-Hodgkin
Activity Summary
Kd 79 meas. best 10.03
IC50 5 meas. best 9.0
Ki 5 meas. best 8.66
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine